Q2 EPS Estimates for Nuvectis Pharma Lifted by HC Wainwright
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Analysts at HC Wainwright raised their Q2 2025 earnings estimates for Nuvectis Pharma in a note issued to investors on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($0.28) per share for the quarter, up from their previous […]
